MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Remote physical activity monitoring programs for Veterans with Parkinson’s disease

    K. Waddell, M. Patel, J. Wilkinson, S. Koganti, S. Wood, J. Morley (Philadelphia, USA)

    Objective: To examine feasibility of a remote physical activity monitoring program and predictors of activity among rural Veterans with PD Background: Patients in rural areas,…
  • 2022 International Congress

    Effect of exercise on motor symptoms, non-motor symptoms and dopamine transporter imaging in Parkinson Disease

    J. Morley, J. Dubroff, G. Cheng, B. Taylor, S. Wood, J. Duda (Philadelphia, USA)

    Objective: To examine the effect of aerobic exercise on motor symptoms, non-motor symptoms (NMS) and dopaminergic denervation, measured by I-123-ioflupane single photon emission computed tomography…
  • 2022 International Congress

    A prospective, controlled study of subthalamic stimulation in Parkinson’s disease: quality of life outcome at the 5-year follow-up

    S. Jost, S. Aloui, A. Rizos, K. Ashkan, J. Evans, A. Sauerbier, J. Petry-Schmelzer, A. Gronostay, G. Fink, M. Barbe, V. Visser-Vandewalle, A. Antonini, M. Silverdale, P. Martinez-Martin, L. Timmermann, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To compare the 60-months quality of life (QoL) effects of subthalamic stimulation (STN-DBS) to standard-of-care oral/transdermal medical therapy (MED) in Parkinson's disease (PD). Background:…
  • 2022 International Congress

    Impact of dopamine replacement therapies on MDS-UPDRS II

    F. Nassan, J. Shirvan, M. Yang, T. Dam, J. Wang, N. Maserejian, W. Flanders (Brookline, USA)

    Objective: To estimate the longitudinal effect of different dopamine therapies on the Movement Disorder Society-Sponsored Unified Parkinson's Disease Rating Scale Part II (MDS-UPDRS II) among…
  • 2022 International Congress

    Predictors of the change in burden and strain among caregivers of Parkinson’s disease patients

    C. Cores Bartolomé, D. Santos García, T. Fonticoba, M. Feal Painceiras, E. Suarez Castro, C. Martinez Miro, S. Jesus Maestre, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. Garcia Caldentey, N. Caballol, I. Legarda, J. Hernandez Vara, I. Cabo, L. Lopez Manzanares, I. Gonzalez Aramburu, MA. Avila Rivera, V. Gomez Mayordomo, V. Nogueira, V. Puente, J. Garcia-Soto, C. Borrue, B. Solano Vila, M. Alvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, JC. Martinez Castrillo, P. Sanchez Alonso, MG. Alonso Losada, MI. Morales Casado, I. Gaston, J. Kulisevsky, M. Blazquez Estrada, M. Seijo, J. Ruiz Martinez, C. Valero, M. Kurtis, O. de Fabregues, J. Gonzalez Ardura, R. Alonso Redondo, C. Ordas, LM. Lopez Diaz, D. Mcafee, P. Martinez Martin, P. Mir (A CORUÑA, Spain)

    Objective: The aim of the present study was to analyze the change in burden and strain after a 2-year follow-up in a cohort of caregivers…
  • 2022 International Congress

    Patient and caregiver satisfaction of video-assisted telenursing in patients treated with LCIG

    T. Gurevich, A. Evans, G. Kägi, D. Koziorowksi, L. Bergmann, JC. Parra Riaza, O. Sanchez-Soliño, J. Slawek (Tel Aviv, Israel)

    Objective: To evaluate the feasibility and patient satisfaction of video-assisted telenursing as well as demonstrate resolution for treatment-related issues in the real-word levodopa-carbidopa intestinal gel…
  • 2022 International Congress

    Illusory responses across the Lewy body disease spectrum

    M. Shahid, A. Rawls, V. Ramirez, S. Ryman, V. Santini, L. Yang, S. Sha, J. Hall, T. Montine, A. Lin, L. Tian, V. Henderson, B. Cholerton, M. Yutsis, K. Poston (Palo Alto, USA)

    Objective: To study pareidolias in patients across the Lewy body disease-spectrum, including those without psychosis. Background: Pareidolias are specific illusions of faces and objects perceived…
  • 2022 International Congress

    The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson’s: a theory-informed qualitative study.

    J. Das, G. Barry, R. Walker, R. Vitorio, R. Morris, S. Stuart (Newcastle upon Tyne, United Kingdom)

    Objective: To explore experiences of people with Parkinson’s (PwP) in using technology as part of a home-based visuo-cognitive training programme compared to traditional approaches to…
  • 2022 International Congress

    Duration of continuous “Good On” intervals and number of motor fluctuations after treatment with IPX203 vs immediate-release carbidopa-levodopa in Parkinson’s disease patients with motor fluctuations.

    R. Hauser, H. Fernandez, J. Aldred, C. Singer, H. Shill, S. Factor, H. Visser, R. D'Souza (Tampa, USA)

    Objective: To compare the duration of continuous “On” without troublesome dyskinesia (“Good On”) intervals and number of motor fluctuations per day in Parkinson’s disease (PD)…
  • 2022 International Congress

    Relationship of satisfaction and adherence in remote digital monitoring: Updated results from a clinical drug trial in early Parkinson’s disease

    B. Fehlmann, A. Thomann, W. Popp, F. Lipsmeier, E. Volkova-Volkmar, J. Friess, H. Svoboda, G. Pagano, T. Kilchemann, A. Bamdadian, W. Zago, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: Extend previous findings from a subset of individuals with early Parkinson’s disease (PD) demonstrating high satisfaction levels with daily remote monitoring with a digital…
  • « Previous Page
  • 1
  • …
  • 230
  • 231
  • 232
  • 233
  • 234
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley